Brian M. Culley

2013 - Mast Therapeutics

In 2013, Brian M. Culley earned a total compensation of $1M as Chief Executive Officer at Mast Therapeutics, a 90% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$191,953
Option Awards$437,655
Salary$393,750
Other$16,140
Total$1,039,498

Culley received $437.7K in option awards, accounting for 42% of the total pay in 2013.

Culley also received $192K in non-equity incentive plan, $393.8K in salary and $16.1K in other compensation.

Rankings

In 2013, Brian M. Culley's compensation ranked 6,422nd out of 12,286 executives tracked by ExecPay. In other words, Culley earned more than 47.7% of executives.

ClassificationRankingPercentile
All
6,422
out of 12,286
48th
Division
Manufacturing
2,255
out of 4,612
51st
Major group
Chemicals And Allied Products
671
out of 1,462
54th
Industry group
Drugs
486
out of 1,156
58th
Industry
Pharmaceutical Preparations
388
out of 890
56th
Source: SEC filing on April 29, 2015.

Culley's colleagues

We found two more compensation records of executives who worked with Brian M. Culley at Mast Therapeutics in 2013.

2013

Patrick Keran

Mast Therapeutics

Chief Operating Officer

2013

Santosh Vetticaden

Mast Therapeutics

Chief Medical Officer

News

You may also like